Enliven Therapeutics, Inc. (ELVN) Stock Price, News, Quote & History

By Yahoo! Finance | Aug 17, 2024 at 09:20 PM EST

Enliven Therapeutics is a biopharmaceutical company in Boulder, CO, developing small molecule inhibitors for cancer treatment. Their lead products, ELVN-001 and ELVN-002, are in Phase 1 trials for chronic myeloid leukemia and solid tumors with HER2 alterations.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.